Viewing Study NCT06612151


Ignite Creation Date: 2025-12-24 @ 11:44 PM
Ignite Modification Date: 2025-12-25 @ 9:37 PM
Study NCT ID: NCT06612151
Status: RECRUITING
Last Update Posted: 2025-02-11
First Post: 2024-09-23
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase III Study of YL201 in Relapsed Small Cell Lung Cancer
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: YL201-CN-302-01
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators